Evotec SE (EVO) Net Income Growth (3y) (2022 - 2026)
Evotec SE (EVO) Net Income Growth (3y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.42 Bn | 87.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.92 Bn | 32.18 Bn | 1.97 Bn | 51.28% |
| 3 | Zoetis | 32.68 Bn | 30.74 Bn | 1.62 Bn | 2.94% |
| 4 | Takeda Pharmaceutical | 27.63 Bn | 23.57 Bn | 4.39 Bn | -62.58% |
| 5 | United Therapeutics | 23.16 Bn | 21.01 Bn | 648.10 Mn | 4.50% |
| 6 | RedHill Biopharma | 21.80 Bn | 21.80 Bn | - | - |
| 7 | Viatris | 20.34 Bn | 18.54 Bn | 1.16 Bn | -7.75% |
| 8 | Neurocrine Biosciences | 17.79 Bn | 16.47 Bn | 800.70 Mn | 66.11% |
| 9 | Elanco Animal Health | 12.65 Bn | 12.22 Bn | 785.00 Mn | -17.90% |
| 10 | Evotec SE | 347.88 Mn | 347.36 Mn | - | -126.17% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -126.17% |
| Dec 31, 2025 | 12.45% |
| Sep 30, 2025 | -30.06% |
| Jun 30, 2025 | -18.19% |
| Mar 31, 2025 | 26.07% |
| Dec 31, 2024 | -41.78% |
| Sep 30, 2024 | -31.52% |
| Jun 30, 2024 | -50.58% |
| Mar 31, 2024 | -33.01% |
| Dec 31, 2023 | -141.43% |
| Sep 30, 2023 | -194.33% |
| Dec 31, 2022 | -85.11% |